Trust Point Inc. Lowers Stock Holdings in Encompass Health Corporation (NYSE:EHC)

Trust Point Inc. lowered its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 50.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,154 shares of the company's stock after selling 2,171 shares during the quarter. Trust Point Inc.'s holdings in Encompass Health were worth $218,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of EHC. Colonial Trust Co SC bought a new stake in Encompass Health during the fourth quarter valued at about $29,000. Transce3nd LLC bought a new position in Encompass Health in the fourth quarter worth about $40,000. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after buying an additional 127 shares in the last quarter. Signaturefd LLC grew its position in shares of Encompass Health by 21.6% in the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after buying an additional 125 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new position in shares of Encompass Health during the 4th quarter worth approximately $72,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

Encompass Health stock traded up $0.68 during trading hours on Thursday, hitting $119.87. 526,464 shares of the stock traded hands, compared to its average volume of 703,029. The firm's 50 day moving average price is $115.12 and its 200-day moving average price is $103.74. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.06 and a quick ratio of 1.06. The stock has a market capitalization of $12.08 billion, a price-to-earnings ratio of 24.77, a P/E/G ratio of 2.42 and a beta of 0.89. Encompass Health Corporation has a 1 year low of $82.74 and a 1 year high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the firm earned $1.12 earnings per share. Encompass Health's revenue for the quarter was up 10.6% on a year-over-year basis. As a group, equities analysts expect that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health's payout ratio is 14.05%.

Insiders Place Their Bets

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This represents a 26.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at approximately $64,054,817.10. This trade represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 132,663 shares of company stock valued at $16,034,082. Company insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on EHC shares. Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Royal Bank Of Canada boosted their target price on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Truist Financial reiterated a "buy" rating and issued a $135.00 price target (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. UBS Group boosted their price target on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Finally, KeyCorp upped their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the company an "overweight" rating in a report on Tuesday, May 27th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health presently has an average rating of "Buy" and an average price target of $127.00.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.